Nutex Health expands its footprint with Post Falls ER & Hospital on the border of Idaho and Washington, serving patients from both states. POST FALLS, Idaho, Aug. 26, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 10 states and primary care-centric, risk-bearing physician networks, today announced the opening of Post Falls ER & Hospital, located at 497 S Beck Road in Post ...

TOTAL REVENUE OF $143.5 MILLION FOR THE FIRST HALF 2024 VS $115.3 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION VISITS OF 81,276 FOR THE FIRST HALF 2024 VS VISITS OF 65,244 FOR THE FIRST HALF 2023, AN INCREASE OF 25% HOSPITAL DIVISION OPERATING INCOME OF $33.3 MILLION FOR THE FIRST HALF 2024 VS $13.9 MILLION FOR THE FIRST HALF 2023, AN INCREASE OF 140% NET CASH FROM OPERATING ACTIVITIES OF $16.3 MILLION FOR THE FIRST HALF 2024 COMPANY CONTINUES ITS FOCUS ON INCREASING CASH FLOW HOUST ...

Financial Performance - Total revenue for the first half of 2024 was $143.5 million, a 25% increase from $115.3 million in the first half of 2023[1] - Total revenue for the three months ended June 30, 2024, was $76,082,261, a 29.1% increase from $58,924,454 in the same period of 2023[8] - Net income for the six months ended June 30, 2024, was $2,467,743, a significant improvement from a net loss of $11,188,418 in the same period of 2023[9] - Adjusted EBITDA for the first half of 2024 was $16.6 million, representing a 159% increase from $6.4 million in the first half of 2023[3] - Adjusted EBITDA for the six months ended June 30, 2024, was $16,599,441, compared to $6,432,393 for the same period in 2023, indicating a 158.5% increase[11] Hospital Division Performance - Hospital division visits increased to 81,276 in the first half of 2024, up 25% from 65,244 visits in the same period of 2023[1] - Operating income for the hospital division reached $33.3 million in the first half of 2024, a significant increase of 140% compared to $13.9 million in the first half of 2023[1] - The company reported a 150% increase in hospital division operating income to $22.8 million for the second quarter of 2024[4] - Total visits from the hospital division for the second quarter of 2024 were 41,208, an increase of 28% from 32,183 visits in the second quarter of 2023[2] - The Hospital Division generated revenue of $67,604,878 for the three months ended June 30, 2024, compared to $51,611,803 in the same period of 2023, reflecting a 30.9% increase[8] Cash and Assets - Cash and cash equivalents as of June 30, 2024, were $40.8 million, up from $22.0 million at the end of 2023[5] - Cash and cash equivalents at the end of the period were $40,807,975, up from $32,754,330 at the end of June 30, 2023[9] - Total assets increased to $422.4 million as of June 30, 2024, compared to $398.2 million at the end of 2023[5] Loss and Expenses - Net loss attributable to Nutex Health Inc. was $0.7 million for the first half of 2024, a reduction from a net loss of $8.6 million in the same period of 2023[3] - The company reported a net loss attributable to Nutex Health Inc. of $(364,048) for the three months ended June 30, 2024, compared to a loss of $(3,479,047) in the same period of 2023[11] - Total operating costs and expenses for the six months ended June 30, 2024, were $110,817,639, an increase from $100,759,225 in the same period of 2023[8] - Interest expense for the six months ended June 30, 2024, was $9,498,894, compared to $7,983,137 for the same period in 2023, indicating a 18.9% increase[11] Operational Insights - Mature hospitals contributed to a 10% revenue growth in the first half of 2024 compared to the same period in 2023[3] - The Population Health Management division operates provider networks, including Independent Physician Associations (IPAs) and offers management services to affiliated hospitals and physician groups[13] - The company utilizes a cloud-based proprietary technology platform that aggregates clinical and claims data to enhance patient and provider care quality[13] Forward-Looking Statements - Forward-looking statements indicate potential risks including execution of growth strategy, regulatory changes, and competition, which could materially affect financial performance[13]

HOUSTON, July 15, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-ofthe-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced Nutex Health hospitals won nine awards in 2024's second quarter, reflecting the staff's commitment to excellence. Each award was voted on by their respective communities, demonstrating patient ...

Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a physicianled, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks with two divisions: a Hospital Division and a Population Health Management Division. SOURCE Nutex Health, Inc. The reverse split was authorized by the Company's shareholders on June 17, 2024, granting the Company's Board of Dire ...

COMPANY EXPECTS TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID REQUIREMENT BEFORE JULY 22, 2024 There can be no assurance that effecting a reverse stock split will result in compliance with the Minimum Bid Price Requirement and the Company cannot predict the effect that a reverse stock split would have on the market price for shares of its Common Stock. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient dep ...

Core Viewpoint - Nutex Health Inc. is facing potential delisting from Nasdaq due to non-compliance with the minimum bid price requirement, but has requested a hearing to appeal this decision [1][2]. Group 1: Delisting and Compliance - On May 21, 2024, Nasdaq notified Nutex Health that its common stock would be delisted due to not meeting the minimum bid price of $1.00, with trading suspension set for May 30, 2024, unless a hearing is requested [1]. - The company submitted a request for a hearing on May 23, 2024, which has temporarily stayed the delisting action, with a hearing scheduled for July 9, 2024 [2]. - The company plans to submit a written response by May 30, 2024, which may allow the Panel to decide without an oral hearing [2]. Group 2: Reverse Stock Split - The Board of Directors approved a reverse stock split with a ratio between 1-for-2 and 1-for-16, pending shareholder approval on June 17, 2024, to regain compliance with Nasdaq's requirements [3]. - The company acknowledges the uncertainty of regaining compliance and obtaining a favorable decision from the Panel [3]. Group 3: Company Overview - Nutex Health Inc. is a healthcare management company founded in 2011, operating 21 micro hospitals across nine states and focusing on integrated healthcare delivery [5]. - The company has two divisions: a Hospital Division that operates innovative healthcare models and a Population Health Management Division that manages provider networks and offers administrative support services [6].

Nutex Health (NASDAQ:NUTX) Q1 2024 Earnings Conference Call May 10, 2024 10:30 AM ET Company Participants Jennifer Rodriguez ??? Investor Relations Manager Tom Vo ??? Chairman and Chief Executive Officer Jon Bates ??? Chief Financial Officer Warren Hosseinion ??? President Josh DeTillio ??? Chief Operating Office Conference Call Participants Bill Sutherland ??? The Benchmark Company Operator Greetings and welcome to the Nutex Health First Quarter 2024 Financial Results Earnings Call. At this time, all part ...

TOTAL REVENUE OF $67.5 MILLION FOR FIRST QUARTER 2024 VS $56.3 MILLION IN 2023, AN INCREASE OF 20% HOSPITAL DIVISION VISITS OF 40,068 FOR THE FIRST QUARTER 2024 VS VISITS OF 33,085 IN 2023, AN INCREASE OF 21.1% HOSPITAL DIVISION OPERATING INCOME OF $10.5 MILLION FOR FIRST QUARTER 2024 VS $4.8 MILLION IN 2023, AN INCREASE OF 119% NET CASH FROM OPERATING ACTIVITIES OF $3.1 MILLION FOR FIRST QUARTER 2024 CONTINUED FOCUS ON INCREASED CASH FLOW THROUGH REDUCTION IN OPERATING EXPENSES AND PORTFOLIO OPTIMIZATION ...

Financial Performance - Total revenue for Q1 2024 was $67.5 million, an increase of 20% compared to $56.3 million in Q1 2023[8] - Hospital division operating income reached $10.5 million, a 119% increase from $4.8 million in the same period last year[8] - Adjusted EBITDA for Q1 2024 was $4.6 million, up 92% from $2.4 million in Q1 2023[8] - Net cash from operating activities was $3.1 million for Q1 2024, compared to $1.1 million in Q1 2023[8] - Net loss attributable to Nutex Health Inc. was $0.4 million, significantly improved from a net loss of $5.1 million in Q1 2023[8] - Net loss attributable to Nutex Health Inc. for Q1 2024 was $364,075, a significant improvement from a net loss of $5,147,279 in Q1 2023[18] - Adjusted EBITDA for Q1 2024 was $4,560,401, compared to $2,437,854 in Q1 2023, reflecting a year-over-year increase of approximately 87%[18] - EBITDA for Q1 2024 was reported at $7,111,981, a substantial increase from $320,588 in the same quarter of the previous year[18] Operational Highlights - Total hospital division visits increased to 40,068 in Q1 2024, a 21.1% rise from 33,085 visits in Q1 2023[8] - Mature hospitals contributed to a 6.7% revenue increase in 2024 compared to 2023[8] - The company opened five new micro hospitals and expanded its population health division over the past 18 months[6] - The Hospital Division operates 21 facilities across nine states, focusing on innovative healthcare models including micro-hospitals and specialty hospitals[19] - The Population Health Management division utilizes a cloud-based proprietary technology platform to aggregate clinical and claims data, enhancing care quality and efficiency[20] Financial Position - The company had $30.0 million in cash and $26.3 million in long-term debt as of March 31, 2024[6] - The balance sheet remains strong with total assets of $404.3 million as of March 31, 2024[8] Expenses and Costs - The company reported interest expense of $4,444,362 for Q1 2024, up from $3,140,089 in Q1 2023, indicating increased borrowing costs[18] - Depreciation and amortization expenses increased to $4,186,202 in Q1 2024 from $3,993,747 in Q1 2023, reflecting ongoing investments in facilities[18] - Stock-based compensation expense decreased to $49,167 in Q1 2024 from $1,900,000 in Q1 2023, indicating a reduction in equity compensation costs[18] Strategic Outlook - The company faces risks related to its growth strategy, regulatory changes, and competition, which could impact future financial performance[22] - Nutex Health Inc. is committed to expanding its provider networks and enhancing management services through its Management Services Organization (MSO)[20]